189 related articles for article (PubMed ID: 15831806)
1. ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia.
Rudel LL; Lee RG; Parini P
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1112-8. PubMed ID: 15831806
[TBL] [Abstract][Full Text] [Related]
2. Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Tomoda H; Doi T
Acc Chem Res; 2008 Jan; 41(1):32-9. PubMed ID: 17803269
[TBL] [Abstract][Full Text] [Related]
3. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver.
Parini P; Davis M; Lada AT; Erickson SK; Wright TL; Gustafsson U; Sahlin S; Einarsson C; Eriksson M; Angelin B; Tomoda H; Omura S; Willingham MC; Rudel LL
Circulation; 2004 Oct; 110(14):2017-23. PubMed ID: 15451793
[TBL] [Abstract][Full Text] [Related]
4. A critical role for the histidine residues in the catalytic function of acyl-CoA:cholesterol acyltransferase catalysis: evidence for catalytic difference between ACAT1 and ACAT2.
An S; Cho KH; Lee WS; Lee JO; Paik YK; Jeong TS
FEBS Lett; 2006 May; 580(11):2741-9. PubMed ID: 16647063
[TBL] [Abstract][Full Text] [Related]
5. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness.
Lada AT; Davis M; Kent C; Chapman J; Tomoda H; Omura S; Rudel LL
J Lipid Res; 2004 Feb; 45(2):378-86. PubMed ID: 14617738
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone.
Yang L; Yang JB; Chen J; Yu GY; Zhou P; Lei L; Wang ZZ; Cy Chang C; Yang XY; Chang TY; Li BL
Cell Res; 2004 Aug; 14(4):315-23. PubMed ID: 15353128
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of ACAT1 and ACAT2 genes in the liver and intestine of baboons with high and low lipemic responses to dietary lipids.
Kushwaha RS; Rosillo A; Rodriguez R; McGill HC
J Nutr Biochem; 2005 Dec; 16(12):714-21. PubMed ID: 16081263
[TBL] [Abstract][Full Text] [Related]
8. Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
Locke JA; Wasan KM; Nelson CC; Guns ES; Leon CG
Prostate; 2008 Jan; 68(1):20-33. PubMed ID: 18000807
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells.
Pramfalk C; Angelin B; Eriksson M; Parini P
Biochem Biophys Res Commun; 2007 Dec; 364(2):402-9. PubMed ID: 17950700
[TBL] [Abstract][Full Text] [Related]
10. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.
Rudel LL; Lee RG; Cockman TL
Curr Opin Lipidol; 2001 Apr; 12(2):121-7. PubMed ID: 11264983
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of acyl-CoA cholesterol acyltransferase by F12511 (Eflucimibe): could it be a new antiatherosclerotic therapeutic?
López-Farré AJ; Sacristán D; Zamorano-León JJ; San-Martín N; Macaya C
Cardiovasc Ther; 2008; 26(1):65-74. PubMed ID: 18466422
[TBL] [Abstract][Full Text] [Related]
12. Compared with Acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol.
Temel RE; Gebre AK; Parks JS; Rudel LL
J Biol Chem; 2003 Nov; 278(48):47594-601. PubMed ID: 12975367
[TBL] [Abstract][Full Text] [Related]
13. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme.
Ohshiro T; Ohte S; Matsuda D; Ohtawa M; Nagamitsu T; Sunazuka T; Harigaya Y; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2008 Aug; 61(8):503-8. PubMed ID: 18997389
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.
Ohshiro T; Rudel LL; Omura S; Tomoda H
J Antibiot (Tokyo); 2007 Jan; 60(1):43-51. PubMed ID: 17390588
[TBL] [Abstract][Full Text] [Related]
16. Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) Inhibitors as hypolipidemic and antiatherosclerosis drugs.
Leon C; Hill JS; Wasan KM
Pharm Res; 2005 Oct; 22(10):1578-88. PubMed ID: 16180116
[TBL] [Abstract][Full Text] [Related]
17. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
18. Isoform-specific inhibitors of ACATs: recent advances and promising developments.
Ohshiro T; Tomoda H
Future Med Chem; 2011 Dec; 3(16):2039-61. PubMed ID: 22098352
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-/- mice.
Bell TA; Brown JM; Graham MJ; Lemonidis KM; Crooke RM; Rudel LL
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1814-20. PubMed ID: 16675724
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of ACAT1 and ACAT2 transcription and activity by long chain free fatty acids in cultured cells.
Seo T; Oelkers PM; Giattina MR; Worgall TS; Sturley SL; Deckelbaum RJ
Biochemistry; 2001 Apr; 40(15):4756-62. PubMed ID: 11294643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
